Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

The main objective was to determine the 2-year clinical benefit and safety of etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended oligoarthritis (eoJIA), enthesitis-related arthritis (ERA), or psoriatic arthritis (PsA).

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Rheumatology 2016-04, Vol.43 (4), p.816-24
Hauptverfasser:	Constantin, Tamas, Foeldvari, Ivan, Vojinovic, Jelena, Horneff, Gerd, Burgos-Vargas, Ruben, Nikishina, Irina, Akikusa, Jonathan D, Avcin, Tadej, Chaitow, Jeffrey, Koskova, Elena, Lauwerys, Bernard R, Calvo Penades, Inmaculada, Flato, Berit, Gamir, Maria Luz, Huppertz, Hans-Iko, Raad, Juan Jose Jaller, Jarosova, Katerina, Anton, Jordi, Macku, Marie, Otero Escalante, William J, Rutkowska-Sak, Lidia, Trauzeddel, Ralf, Velez-Sanchez, Patricia J, Wouters, Carine, Wajdula, Joseph, Zang, Chuanbo, Bukowski, Jack, Woodworth, Deborah, Vlahos, Bonnie, Martini, Alberto, Ruperto, Nicolino
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The main objective was to determine the 2-year clinical benefit and safety of etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended oligoarthritis (eoJIA), enthesitis-related arthritis (ERA), or psoriatic arthritis (PsA).
ISSN:	0315-162X